Widespread immunization against varicella has resulted in considerable reduction of the incidence of chickenpox throughout the world. Mortality due to varicella was also decreased since the initiation of vaccination program, with approximately 66% reduction in some studies (
1-
3). Therefore, knowledge on the seroprevalence of varicella can lead to development and improvement of vaccination strategies and minimization of the economic load. Adverse events of infectious diseases, particularly chickenpox, can pose higher threat to military personnel and conscripts because of higher exposure to extreme temperatures, higher mobility, and often, hostile environmental conditions, especially if they fail to develop immunity prior to enlistment (
4,
5). The American academy of pediatrics and the advisory committee on immunization practices (ACIP) expanded its recommendations to promote varicella vaccination for military personnel, as one of the susceptible and high-risk groups for this infection (
6). Developing strategies to prevent varicella morbidity in some developed countries, such as the United States, led to a decline in the number and incidence of varicella hospitalizations for army active duty soldiers in the recent decade (
7-
9). In Iran, as a developing country, some investigations were done to determine immunological status against chickenpox in different age subgroups, which revealed that the prevalence of antibodies to varicella gradually increased throughout adolescence and adulthood (
10). No data on immunization against varicella among military personnel and conscripts have been published in Iran.